162 related articles for article (PubMed ID: 34638497)
1. EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
April-Monn SL; Andreasi V; Schiavo Lena M; Sadowski MC; Kim-Fuchs C; Buri MC; Ketkar A; Maire R; Di Domenico A; Schrader J; Muffatti F; Doglioni C; Partelli S; Falconi M; Perren A; Marinoni I
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638497
[TBL] [Abstract][Full Text] [Related]
2. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
3. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
4. Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects.
Gulde S; Foscarini A; April-Monn SL; Genio E; Marangelo A; Satam S; Helbling D; Falconi M; Toledo RA; Schrader J; Perren A; Marinoni I; Pellegata NS
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428573
[TBL] [Abstract][Full Text] [Related]
5. Chronological improvement of pancreatectomy for resectable but advanced pancreatic neuroendocrine neoplasms.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K
Pancreatology; 2022 Dec; 22(8):1141-1147. PubMed ID: 36404199
[TBL] [Abstract][Full Text] [Related]
6. PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia.
Zhou J; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Dai W; Wang Y; Jin Y; Pan J
Clin Cancer Res; 2018 Jan; 24(1):145-157. PubMed ID: 29070525
[No Abstract] [Full Text] [Related]
7. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
Front Oncol; 2020; 10():831. PubMed ID: 32537434
[TBL] [Abstract][Full Text] [Related]
9. Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.
Zeng D; Liu M; Pan J
Oncotarget; 2017 Jan; 8(2):3396-3411. PubMed ID: 27926488
[TBL] [Abstract][Full Text] [Related]
10. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
11. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.
Tiffen JC; Gunatilake D; Gallagher SJ; Gowrishankar K; Heinemann A; Cullinane C; Dutton-Regester K; Pupo GM; Strbenac D; Yang JY; Madore J; Mann GJ; Hayward NK; McArthur GA; Filipp FV; Hersey P
Oncotarget; 2015 Sep; 6(29):27023-36. PubMed ID: 26304929
[TBL] [Abstract][Full Text] [Related]
12. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
13. Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms.
Palmieri LJ; Dermine S; Barré A; Dhooge M; Brezault C; Cottereau AS; Coriat R
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549203
[TBL] [Abstract][Full Text] [Related]
14. Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer.
Hu J; Zheng Z; Lei J; Cao Y; Li Q; Zheng Z; Chen C
PPAR Res; 2021; 2021():5589342. PubMed ID: 34335707
[TBL] [Abstract][Full Text] [Related]
15. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
[TBL] [Abstract][Full Text] [Related]
16. The epigenetic modification during the induction of Foxp3 with sodium butyrate.
Cao T; Zhang X; Chen D; Zhang P; Li Q; Muhammad A
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):309-318. PubMed ID: 30003817
[TBL] [Abstract][Full Text] [Related]
17. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
18. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E.
Yiew NKH; Greenway C; Zarzour A; Ahmadieh S; Goo B; Kim D; Benson TW; Ogbi M; Tang YL; Chen W; Stepp D; Patel V; Hilton R; Lu XY; Hui DY; Kim HW; Weintraub NL
J Biol Chem; 2019 May; 294(21):8577-8591. PubMed ID: 30971429
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis.
Harms KL; Chubb H; Zhao L; Fullen DR; Bichakjian CK; Johnson TM; Carskadon S; Palanisamy N; Harms PW
Hum Pathol; 2017 Sep; 67():78-84. PubMed ID: 28739498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
